| 摘要 |
<p>The invention relates to the use of a lipido-sterolic Serenoa Repens extract for the production of a medicament which is administered in an isolated manner or in an associated manner, in a simultaneous, separated or staggered manner, with prostatectomy, radiotherapy and/or hormonotherapy in order to prevent and/or treat prostate cancer.</p> |
